𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2α receptor

✍ Scribed by Thomas J. Weber; Lye M. Markillie; William B. Chrisler; George A. Vielhauer; John W. Regan


Book ID
102499841
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
198 KB
Volume
35
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Prostaglandin F~2α~ (PGF~2α~) modulates clonal selection processes in the mouse skin model of carcinogenesis. In this study we investigated whether JB6 mouse epidermal cells expressed a functional PGF~2α~ receptor (FP) coupled with a cell‐transformation response. Treatment of JB6 cells with an FP agonist (fluprostenol) potently (pM‐nM) increased anchorage‐dependent and anchorage‐independent growth. Inositol phospholipid accumulation and extracellular signal–regulated kinase (Erk) activity were increased in cells treated with FP agonists, consistent with established FP‐related signal transduction. FP mRNA was detected by reverse transcription–polymerase chain reaction, and the average specific [^3^H]PGF~2α~ binding was 8.25 ± 0.95 fmol/mg protein. Erk activity and colony size were increased by cotreatment of JB6 cells with epidermal growth factor (EGF) and fluprostenol to a greater extent than with either treatment alone, whereas the cotreatment effect on colony number appeared to be simply additive. Collectively, our data indicated that JB6 cells expressed a functional FP coupled with transformation‐related signal transduction and the regulation of clonal selection processes. Erk activity appears to be a convergence point in the EGF and FP pathways. The data raise the possibility that the FP contributes to clonal selection processes but probably plays a more important role as a response modifier. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Mevalonate dependency of the early cell
✍ Marcela B. Ortiz; Mercedes Goin; Maria B. Gomez de Alzaga; Swen Hammarstrom; Lui 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

Lovastatin (LOV), a hydroxy-methylglutaryl-coenzyme A (HMGCoA) reductase competitive inhibitor, blocks epidermal growth factor (EGF)or prostaglandin F , , (PGF,,)-induced mitogenesis in confluent resting Swiss 3T3 cells. This inhibition occurs even in the presence of insulin, which potentiates the a